Zobrazeno 1 - 8
of 8
pro vyhledávání: '"SHI‑BIN JIANG"'
Autor:
Yan-Song Lu, Yuan Jiang, Jin-ping Yuan, Shi-Bin Jiang, Yang Yang, Pei-yao Zhu, Yu-zhe Sun, Rui-qun Qi, Tao Liu, He-Xiao Wang, Yan Wu, Xing-Hua Gao, Hong-duo Chen
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Photodamages caused by UVA radiation induced oxidative injuries are closely related to photoaging and skin cancer. Paeoniflorin (PF), extracted from the root of Paeonia lactiflora, has been reported to be an effective antioxidant. PLIN2, known as adi
Externí odkaz:
https://doaj.org/article/839172e028ac4abfb4b6d3f7f6256729
Autor:
Shi-Ling Wang, Juan Li, Yong-Hang Li, Shao-Song Qian, Jie Qin, Jian-Ping Ma, Shi-Bin Jiang, Yu Zhang
Publikováno v:
Journal of Coordination Chemistry. 74:1522-1533
Reactions of 2-{[5-(Pyridin-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid (H2L) with manganese(II), zinc(II) and cadmium(II) acetate in CH3OH/H2O mixture result in the corresponding metal complexes. All the obtained complexes were characterized by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaa12ac3ab2f70da7b3cde18c9f4ea8e
https://doi.org/10.1080/00958972.2021.1900832
https://doi.org/10.1080/00958972.2021.1900832
Autor:
Hou‑Quan Tao, Jun‑Gang Luo, Xujun He, Jian‑Zhong Chen, Shi‑Bin Jiang, Xiao‑Ting Jiang, Zheng‑Chuang Liu, Ying‑Jie Xia, Liang Wang
Publikováno v:
Molecular Medicine Reports. 16:6882-6889
Prolyl hydroxylase 3 (PHD3) is widely accepted as a tumor suppressor; however, the expression of PHD3 in various cancer types remains controversial. The present study aimed to investigate the association between PHD3 expression and the clinicopatholo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3044fbe7d1ef2e2ec3d4906937b64541
https://doi.org/10.3892/mmr.2017.7455
https://doi.org/10.3892/mmr.2017.7455
Autor:
Shi-Bin Jiang1, Xu-Jun He1, Ying-Jie Xia1, Wei-Jian Hu1, Jun-Gang Luo1, Jun Zhang1,2,3, Hou-Quan Tao1 taohouquan2008@aliyun.com
Publikováno v:
OncoTargets & Therapy. Apr2016, Vol. 9, p2305-2315. 10p.
Publikováno v:
OncoTargets and therapy
Shi-Bin Jiang,1,2,* Xu-Jun He,1,3,* Ying-Jie Xia,1,3 Wei-Jian Hu,2 Jun-Gang Luo,1,2 Jun Zhang,2,3 Hou-Quan Tao1–31Department of Surgery, Zhejiang Provincial People’s Hospital, Hangzhou, 2Wenzhou Medical University, Wenzhou, 3Key Laboratory of Gas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f516982687a490f5c998d63a6b6253
https://pubmed.ncbi.nlm.nih.gov/27143926
https://pubmed.ncbi.nlm.nih.gov/27143926
Autor:
JIAN‑ZHONG CHEN, YING‑JIE XIA, XIAO‑TING JIANG, SHI‑BIN JIANG, XU‑JUN HE, JUN‑GANG LUO, ZHENG‑CHUANG LIU, HOU‑QUAN TAO, LIANG WANG
Publikováno v:
Molecular Medicine Reports; Nov2017, Vol. 16 Issue 5, p6882-6889, 8p, 1 Color Photograph, 2 Charts, 4 Graphs
Autor:
Ying-Yu Ma, Wei-Quan Wu, Zheng-Chuang Liu, Xiao-Fen Yu, Kun Guo, Qi-Wen He, Shi-Bin Jiang, Qin-Shu Shao, Hou-Quan Tao, Dong-Sheng Huang
Publikováno v:
World Journal of Surgical Oncology; 6/27/2016, Vol. 14, p1-7, 7p
Autor:
Xiao-Fen Yu, Dong-Sheng Huang, Kun Guo, Qi-Wen He, Ying-Yu Ma, Qin-Shu Shao, Shi-Bin Jiang, Wei-Quan Wu, Zhengchuang Liu, Hou-Quan Tao
Publikováno v:
World Journal of Surgical Oncology
Background Numerous epidemiological studies have evaluated the association between the CDH1 -160C/A polymorphism and the risk of breast cancers. However, these studies have yielded conflicting results. To derive a more precise estimation of this asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecdf14b8d338a3c2b922b14993cfc93